OPRX

OptimizeRx Corporation Common Stock

9.15

USD

+0.07

+0.77%

Oct 23, 15:59 UTC -4

Closed

After-Market

9.11

-0.04

-0.49%

OptimizeRx Corporation Common Stock (OPRX) Earnings

OPRX Earnings Reports

Positive Surprise Ratio

OPRX beat 31 of 38 last estimates.

82%

Next Report

Date of Next Report

Nov 10, 2026

Estimate for Q3 26 (Revenue/ EPS)

$21.61M

$0.17

Implied change from Q2 26 (Revenue/ EPS)

+5.40%

+6.25%

Implied change from Q3 25 (Revenue/ EPS)

-17.09%

-15.00%

OptimizeRx Corporation Common Stock earnings per share and revenue

On Aug 12, 2026, OPRX reported earnings of 0.16 USD per share (EPS) for Q2 26, beating the estimate of 0.07 USD, resulting in a 101.01% surprise. Revenue reached 20.50 million, compared to an expected 20.61 million, with a -0.50% difference. The market reacted with a +24.72% price change (close before vs. close after earnings).

Looking ahead to Q3 26, 9 analysts forecast an EPS of 0.17 USD, with revenue projected to reach 21.61 million USD, implying an increase of 6.25% EPS, and increase of 5.40% in Revenue from the last quarter.

Industry Peers’ Earnings

Industry Peers' Earnings displays EPS earnings data from companies in the same industry. Click on a card to view more details.

SAP SE

Report Date

Oct 21, 2026 For Q3 26

Estimate

$1.87

Actual

$1.94

Surprise

+3.78%

SS&C Technologies Inc

Report Date

Oct 22, 2026 For Q3 26

Estimate

$1.80

Actual

$1.78

Surprise

-1.22%

Pegasystems Inc

Report Date

Oct 20, 2026 For Q3 26

Estimate

$0.49

Actual

$0.35

Surprise

-29.01%

FAQ

What were OptimizeRx Corporation Common Stock's earnings and revenue for the latest quarter Q2 2026?

For Q2 2026, OptimizeRx Corporation Common Stock reported EPS of $0.16, beating estimates by 101.01%, and revenue of $20.50M, -0.5% below expectations.

How did the market react to OptimizeRx Corporation Common Stock's Q2 2026 earnings?

The stock price moved up 24.72%, changed from $7.04 before the earnings release to $8.78 the day after.

When is OptimizeRx Corporation Common Stock expected to report next?

The next earning report is scheduled for Nov 10, 2026.

What are the forecasts for OptimizeRx Corporation Common Stock's next earnings report?

Based on 9 analysts, OptimizeRx Corporation Common Stock is expected to report EPS of $0.17 and revenue of $21.61M for Q3 2026.

Which companies are reporting earnings today?

Check FXEmpire's Earnings Calendar for today's list of reporting companies.